B Braun buys McGaw for $320 million:
This article was originally published in Clinica
German company B Braun Melsungen has bought Ivax subsidiary McGaw, which makes intravenous solutions and related products, for around $320 million. B Braun will make additional payments of up to $80 million, depending on the operating results of McGaw and B Braun's US subsidiary. US company Ivax will receive royalties based on B Braun and McGaw's commercialisation of Duplex, a multi-compartment drug-delivery system designed for intravenous drugs that have limited stability after mixing.